Compare FOLD & ADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOLD | ADX |
|---|---|---|
| Founded | 2002 | 1840 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.7B |
| IPO Year | 2007 | N/A |
| Metric | FOLD | ADX |
|---|---|---|
| Price | $9.92 | $23.02 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $30.29 | N/A |
| AVG Volume (30 Days) | ★ 4.6M | 182.4K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.68% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $598,704,000.00 | N/A |
| Revenue This Year | $21.12 | N/A |
| Revenue Next Year | $21.23 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 21.28 | N/A |
| 52 Week Low | $5.51 | $14.94 |
| 52 Week High | $10.57 | $19.57 |
| Indicator | FOLD | ADX |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 52.01 |
| Support Level | $9.56 | $22.48 |
| Resistance Level | $10.05 | $23.85 |
| Average True Range (ATR) | 0.37 | 0.33 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 51.14 | 44.93 |
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally managed closed-end fund whose investment objectives are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It invests a majority of its assets in very liquid S&P 500 stocks, and has broad flexibility in the selection of stocks, but maintains a sector neutral approach. The fund has a diversified equity portfolio which consists of securities of companies from energy, consumer staples, information technology, financials, and other sectors.